TNFSF10 and metastatic malignant neoplasm: Together, these findings indicate that TRAIL-based liposomal therapy is a potential therapy that could be used to efficiently target and eradicate CTCs to enhance overall survival in patients diagnosed with advanced metastatic cancer.